Loading...
The Joint Corp.
JYNT•NASDAQ
Healthcare
Medical - Care Facilities
$11.70
$0.32(2.81%)
The Joint Corp. (JYNT) Financial Performance & Income Statement Overview
Review The Joint Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-55.91%
↓ 55.91%
Operating Income Growth
15.34%
↑ 15.34%
Net Income Growth
12.53%
↑ 12.53%
Operating Cash Flow Growth
-35.85%
↓ 35.85%
Operating Margin
-4.57%
↓ 4.57%
Gross Margin
63.48%
↑ 63.48%
Net Profit Margin
-24.61%
↓ 24.61%
ROE
-42.58%
↓ 42.58%
ROIC
-4.67%
↓ 4.67%
The Joint Corp. (JYNT) Income Statement & Financial Overview
Review The Joint Corp.'s (JYNT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$38.28M | $30.20M | $30.26M | $29.72M |
| Cost of Revenue | $3.15M | $2.82M | $4.35M | $4.12M |
| Gross Profit | -$41.44M | $27.38M | $25.91M | $25.60M |
| Gross Profit Ratio | $1.08 | $0.91 | $0.86 | $0.86 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$36.88M | $25.52M | $27.49M | $24.15M |
| Operating Expenses | $9.96M | $30.56M | $27.49M | $24.15M |
| Total Costs & Expenses | -$42.12M | $33.38M | $31.84M | $28.27M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $345530.00 | $1.24M | $1.52M | $1.40M |
| EBITDA | $1.37M | $1.86M | -$538854.00 | $2.86M |
| EBITDA Ratio | -$0.04 | $0.06 | -$0.02 | $0.10 |
| Operating Income | $953808.00 | -$3.19M | -$1.58M | $1.45M |
| Operating Income Ratio | -$0.02 | -$0.11 | -$0.05 | $0.05 |
| Other Income/Expenses (Net) | $69604.00 | $83333.00 | $79910.00 | -$326474.00 |
| Income Before Tax | $1.02M | -$3.10M | -$3.42M | $1.13M |
| Income Before Tax Ratio | -$0.03 | -$0.10 | -$0.11 | $0.04 |
| Income Tax Expense | $37.00B | $62585.00 | $178322.00 | $178927.00 |
| Net Income | -$2.72M | -$3.17M | -$3.60M | $946979.00 |
| Net Income Ratio | $0.07 | -$0.10 | -$0.12 | $0.03 |
| EPS | -$0.18 | -$0.21 | -$0.24 | $0.06 |
| Diluted EPS | -$0.18 | -$0.21 | -$0.24 | $0.06 |
| Weighted Avg Shares Outstanding | $14.96M | $14.96M | $14.95M | $14.80M |
| Weighted Avg Shares Outstanding (Diluted) | $14.96M | $15.14M | $14.95M | $14.80M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan